spacer
spacer

PDBsum entry 1tk3

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase PDB id
1tk3

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
726 a.a. *
Ligands
NAG-NAG-FUC ×3
NAG-NAG ×4
NAG-NDG-MAN
NAG-NAG-BMA ×2
NAG-NDG
NAG ×3
Waters ×1211
* Residue conservation analysis
PDB id:
1tk3
Name: Hydrolase
Title: Crystal structure of human apo dipeptidyl peptidase iv/cd26
Structure: Dipeptidyl peptidase iv. Chain: a, b. Fragment: extracellular domain. Synonym: dpp iv, t-cell activation antigen cd26, tp103, adenosine deaminase complexing protein-2, adabp. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: dpp4, adcp2, cd26. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: high5.
Biol. unit: Dimer (from PQS)
Resolution:
2.00Å     R-factor:   0.229     R-free:   0.272
Authors: J.R.Bjelke,J.Christensen,S.Branner,N.Wagtmann,C.Olsen,A.B.Kanstrup, H.B.Rasmussen
Key ref:
J.R.Bjelke et al. (2004). Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV. J Biol Chem, 279, 34691-34697. PubMed id: 15175333 DOI: 10.1074/jbc.M405400200
Date:
08-Jun-04     Release date:   06-Jul-04    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P27487  (DPP4_HUMAN) -  Dipeptidyl peptidase 4 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
766 a.a.
726 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.3.4.14.5  - dipeptidyl-peptidase Iv.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Release of an N-terminal dipeptide, Xaa-Xbb-|-Xcc, from a polypeptide, preferentially when Xbb is Pro, provided Xcc is neither Pro nor hydroxyproline.

 

 
DOI no: 10.1074/jbc.M405400200 J Biol Chem 279:34691-34697 (2004)
PubMed id: 15175333  
 
 
Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV.
J.R.Bjelke, J.Christensen, S.Branner, N.Wagtmann, C.Olsen, A.B.Kanstrup, H.B.Rasmussen.
 
  ABSTRACT  
 
Human dipeptidyl peptidase IV (DPP-IV) is a ubiquitously expressed type II transmembrane serine protease. It cleaves the penultimate positioned prolyl bonds at the N terminus of physiologically important peptides such as the incretin hormones glucagon-like peptide 1 and glucose-dependent insulinotropic peptide. In this study, we have characterized different active site mutants. The Y547F mutant as well as the catalytic triad mutants S630A, D708A, and H740L showed less than 1% wild type activity. X-ray crystal structure analysis of the Y547F mutant revealed no overall changes compared with wild type apoDPP-IV, except the ablation of the hydroxyl group of Tyr(547) and a water molecule positioned in close proximity to Tyr(547). To elucidate further the reaction mechanism, we determined the crystal structure of DPP-IV in complex with diisopropyl fluorophosphate, mimicking the tetrahedral intermediate. The kinetic and structural findings of the tyrosine residue are discussed in relation to the catalytic mechanism of DPP-IV and to the inhibitory mechanism of the 2-cyanopyrrolidine class of potent DPP-IV inhibitors, proposing an explanation for the specificity of this class of inhibitors for the S9b family among serine proteases.
 
  Selected figure(s)  
 
Figure 1.
FIG. 1. The structure of one monomer of DPP-IV in complex with ValPyr and close-up of the active site. The -propeller and the / hydrolase domains are shown in purple and brown, respectively. Residues in close proximity of the ValPyr inhibitor are shown with interatomic distances. See text for details.
Figure 4.
FIG. 4. Close-up of active site residues. The initial F[o] - F[c] electron density maps are overlaid the apoDPP-IV (A), Y547F mutant (B), and complex DFP·DPP-IV (C, slightly different view, relative to A and B) contoured at 2 (cyan), 3 (red), 5 (purple, only contoured in the apo structure), and 8 (blue, only contoured in the DFP structure). The initial 2F[o] - F[c] electron density map is overlaid the complex DFP·DPP-IV contoured at 1 (gray). Structural inspections of the active site of the Y547F mutant reveals a missing water molecule, clearly seen in the wild type apo structure (i.e. hydrogen bonds between Tyr547-OH, Ser630-OH, and Tyr631-NH are indicated). The mutated residue (Phe^547) is positioned exactly as the tyrosine residue. The water molecule designated Wat258 and Wat421 in the apo and the Y547F mutant structure, respectively, is moved 0.5 Å away from the 547 residue and 0.3 Å (2.9 versus 3.2 Å) closer to the neighboring Tyr666-OH (not shown) in the mutant structure. The complex between DFP and DPP-IV showed that the organophosphorous inhibitor was covalently bound to Ser630, mimicking the tetrahedral intermediate.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2004, 279, 34691-34697) copyright 2004.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
  21465558 C.Li, J.Shen, W.Li, C.Lu, G.Liu, and Y.Tang (2011).
Possible ligand release pathway of dipeptidyl peptidase IV investigated by molecular dynamics simulations.
  Proteins, 79, 1800-1809.  
20536396 M.R.Pitman, R.I.Menz, and C.A.Abbott (2010).
Hydrophilic residues surrounding the S1 and S2 pockets contribute to dimerisation and catalysis in human dipeptidyl peptidase 8 (DP8).
  Biol Chem, 391, 959-972.  
19509064 A.G.Sandström, K.Engström, J.Nyhlén, A.Kasrayan, and J.E.Bäckvall (2009).
Directed evolution of Candida antarctica lipase A using an episomaly replicating yeast plasmid.
  Protein Eng Des Sel, 22, 413-420.  
19676137 K.McNicholas, T.Chen, and C.A.Abbott (2009).
Dipeptidyl peptidase (DP) 6 and DP10: novel brain proteins implicated in human health and disease.
  Clin Chem Lab Med, 47, 262-267.  
18989859 I.M.Al-Masri, M.K.Mohammad, and M.O.Taha (2008).
Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.
  ChemMedChem, 3, 1763-1779.  
18227430 W.J.Metzler, J.Yanchunas, C.Weigelt, K.Kish, H.E.Klei, D.Xie, Y.Zhang, M.Corbett, J.K.Tamura, B.He, L.G.Hamann, M.S.Kirby, and J.Marcinkeviciene (2008).
Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation.
  Protein Sci, 17, 240-250.
PDB code: 3bjm
18820015 Y.Nakajima, K.Ito, T.Toshima, T.Egawa, H.Zheng, H.Oyama, Y.F.Wu, E.Takahashi, K.Kyono, and T.Yoshimoto (2008).
Dipeptidyl aminopeptidase IV from Stenotrophomonas maltophilia exhibits activity against a substrate containing a 4-hydroxyproline residue.
  J Bacteriol, 190, 7819-7829.
PDB code: 2ecf
17704566 C.Oefner, S.Pierau, H.Schulz, and G.E.Dale (2007).
Structural studies of a bifunctional inhibitor of neprilysin and DPP-IV.
  Acta Crystallogr D Biol Crystallogr, 63, 975-981.
PDB code: 2qpj
17068815 C.Rummey, and G.Metz (2007).
Homology models of dipeptidyl peptidases 8 and 9 with a focus on loop predictions near the active site.
  Proteins, 66, 160-171.  
17492130 H.Hiramatsu, K.Kyono, A.Yamamoto, K.Saeki, H.Shima, S.Sugiyama, K.Inaka, and R.Shimizu (2007).
Crystal structures of human dipeptidyl peptidase IV in its apo and diprotin B-complexed forms.
  Acta Biochim Biophys Sin (Shanghai), 39, 335-343.  
17676345 R.R.Pissurlenkar, M.S.Shaikh, and E.C.Coutinho (2007).
3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment.
  J Mol Model, 13, 1047-1071.  
17047060 D.Chen, A.Kennedy, J.Y.Wang, W.Zeng, Q.Zhao, M.Pearl, M.Zhang, Z.Suo, J.M.Nesland, Y.Qiao, A.K.Ng, N.Hirashima, T.Yamane, Y.Mori, M.Mitsumata, G.Ghersi, and W.T.Chen (2006).
Activation of EDTA-resistant gelatinases in malignant human tumors.
  Cancer Res, 66, 9977-9985.  
  17119608 C.J.Chihara, C.Song, G.LaMonte, K.Fetalvero, K.Hinchman, H.Phan, M.Pineda, K.Robinson, and G.P.Schneider (2005).
Identification and partial characterization of the enzyme of omega: one of five putative DPP IV genes in Drosophila melanogaster.
  J Insect Sci, 5, 26.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer